Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Human Milk Bank Foundation | UNKNOWN |
| NutroPharma | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Femaltiker is a food for special medical purposes with a unique composition. Because beer, but not ethanol, has been reported in a number of studies to stimulate prolactin levels and breastmilk production, polysaccharide from barley was chosen as a potential galactogogue. To verify our assumption, a randomized, double blinded research with placebo was performed. The study was conducted according to good clinical practice and 10% of output data was audited by the outside monitor. The research was conducted from 14 April 2014 to 7 October 2015 in two NICUs with consent of the ethics committee on Medical Warsaw University.
The traget population consisted of volunteers women who delivered infants at < 37 weeks gestation. Criteria of exclusion were: hypothyroidism and diabetes type I or II diagnosed and treated before pregnancy.
The schedule of the study included three visits with in certain point time during two weeks postpartum. During the study patients had taken twice a day product or placebo, respectively. The protocol of the study included :
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Femaltiker | Experimental | 7.7 g of Femaltiker twice a day for 14 days of the trial. |
|
| placebo | Placebo Comparator | 7.7 g placebo 14 days of the trial. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Femaltiker | Other | Patient had taken twice a day the product |
|
| Measure | Description | Time Frame |
|---|---|---|
| The volume of milk produced by study participants | Measurement of the volume of expressed milk | two weeks after delivery |
| Level of serum prolactin | Three consecutive blood collections for prolactin level | two weeks after delivery |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Aleksandra Wesolowska, PhD | Warsaw Medical University, Department of Neonatology | Study Director |
| Maria K. Borszewska-Kornacka, Prof. | Warsaw Medical University Hospital, Department of Neonatology and Intensive Care Unit | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Warsaw Medical University Hospital | Warsaw | 00315 | Poland | |||
| Mother and Child Health Center of Warsaw Medical University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007752 | Obstetric Labor, Premature |
| ID | Term |
|---|---|
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Treatment was given to the mothers assigned to the galactogogue group, whereas a placebo was given to those assigned to the placebo group. Each patient randomized to either treatment or placebo group received 28 sachets for 14 days of the trial.
Not provided
Not provided
To mask intervention the placebo was used. In this case, the placebo was prepared as a blend of sucrose, apple fiber and natural aroma caramel by subcontractor of the producer, accordingly to the GMP (number of sachets prepared 1534). Placebo sachets were in the same size sachets as the product and could be hardly distinguished in term of color, taste or texture and flavor. To the end of the trial patients and medical staff were blinded which sachet contained active product. People responsible for the data clean-up and statistics were partially blinded since theyhad to know which patients were in the same treatment group.
| Placebo | Other | Patient had taken twice a day the placebo |
|
| Warsaw |
| 02015 |
| Poland |
| Laboratory of Human Milk and Lactation Research at Regional Human Milk Bank in Holy Family Hospital | Warsaw | 02091 | Poland |
| Warsaw Medical University - Clinic of Neonatology | Warsaw | 02091 | Poland |